Does ABALOPARATIDE Cause Product dose omission issue? 1,006 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,006 reports of Product dose omission issue have been filed in association with ABALOPARATIDE (Tymlos). This represents 4.3% of all adverse event reports for ABALOPARATIDE.
1,006
Reports of Product dose omission issue with ABALOPARATIDE
4.3%
of all ABALOPARATIDE reports
0
Deaths
78
Hospitalizations
How Dangerous Is Product dose omission issue From ABALOPARATIDE?
Of the 1,006 reports, 78 (7.8%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABALOPARATIDE. However, 1,006 reports have been filed with the FAERS database.
What Other Side Effects Does ABALOPARATIDE Cause?
Headache (4,048)
Nausea (3,134)
Dizziness (3,005)
Fatigue (2,637)
Heart rate increased (2,092)
Palpitations (1,730)
Arthralgia (1,711)
Bone pain (1,360)
Back pain (1,229)
Pain (1,191)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ABALOPARATIDE Alternatives Have Lower Product dose omission issue Risk?
ABALOPARATIDE vs ABATACEPT
ABALOPARATIDE vs ABATACEPT SUBQ /ML
ABALOPARATIDE vs ABCIXIMAB
ABALOPARATIDE vs ABEMACICLIB
ABALOPARATIDE vs ABILIFY